Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$41.09 USD
+0.84 (2.09%)
Updated May 31, 2024 03:59 PM ET
After-Market: $41.13 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 401 - 420 ( 441 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company to Acquire Amylin Pharmaceuticals, Expand Partnership with AstraZeneca
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
First Quarter Results in Line with Expectations
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Fourth Quarter Revenue Moved Up 7% With No Currency Tailwind
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of January 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Solid Performance from Existing Products with More on the Way
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES -The Week Ahead in Life Sciences - Upcoming Events for the Week of September 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
New Products and Currency Contribute to Mid- Teens Second Quarter Sales Growth.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S